Publication

Northern New Jersey Q4 2024 Life Sciences Market Overview

Article

Contacts & Related Research

Image treatment

Market Highlights

  • Claris Bio raised $57.0 million, New Jersey's largest life sciences funding in 2024, to advance its neurotrophic keratopathy treatment.
  • Six major BioNJ members, including Amicus Therapeutics and Bristol Myers Squibb, launched the "Time Off for Clinical Trials" policy, offering employees paid time off to participate in clinical trials.
  • The National Institutes of Health (NIH) has awarded Rutgers University a $50.0 million grant to support research planned at the HELIX Science and Technology Campus in New Brunswick.

Read the full report